Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 59326 - 59350 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Piroxicam	Approved Investigational	LY6E	4061	downregulated	Piroxicam results in decreased expression of LY6E mRNA	8q24.3	A21015
Piroxicam	Approved Investigational	MAD2L1	4085	upregulated	Piroxicam results in increased expression of MAD2L1 mRNA	4q27	A23661
Piroxicam	Approved Investigational	MAGOH	4116	upregulated	Piroxicam results in increased expression of MAGOH mRNA	1p32.3	A23661
Piroxicam	Approved Investigational	MANF	7873	downregulated	Piroxicam results in decreased expression of MANF mRNA	3p21.2	A23661
Piroxicam	Approved Investigational	MARCKS	4082	downregulated	Piroxicam results in decreased expression of MARCKS mRNA	6q21	A21015
Piroxicam	Approved Investigational	MARS	4141	downregulated	Piroxicam results in decreased expression of MARS mRNA	12q13.3	A23661
Piroxicam	Approved Investigational	MCAM	4162	downregulated	Piroxicam results in decreased expression of MCAM mRNA	11q23.3	A23661
Piroxicam	Approved Investigational	MCM3	4172	downregulated	Piroxicam results in decreased expression of MCM3 mRNA	6p12.2	A23661
Piroxicam	Approved Investigational	MCM4	4173	downregulated	Piroxicam results in decreased expression of MCM4 mRNA	8q11.21	A23661
Piroxicam	Approved Investigational	MCM5	4174	upregulated	Piroxicam results in increased expression of MCM5 mRNA	22q12.3	A23661
Piroxicam	Approved Investigational	MCM6	4175	downregulated	Piroxicam results in decreased expression of MCM6 mRNA	2q21.3	A23661
Piroxicam	Approved Investigational	MDK	4192	upregulated	Piroxicam results in increased expression of MDK mRNA	11p11.2	A23661
Piroxicam	Approved Investigational	MED21	9412	downregulated	Piroxicam results in decreased expression of MED21 mRNA	12p12	A23661
Piroxicam	Approved Investigational	MEIS2	4212	downregulated	Piroxicam results in decreased expression of MEIS2 mRNA	15q14	A23661
Piroxicam	Approved Investigational	MEST	4232	downregulated	Piroxicam results in decreased expression of MEST mRNA	7q32.2	A23661
Piroxicam	Approved Investigational	MET	4233	downregulated	Piroxicam results in decreased expression of MET mRNA	7q31	A21015
Piroxicam	Approved Investigational	MGAT2	4247	downregulated	Piroxicam results in decreased expression of MGAT2 mRNA	14q21.3	A23661
Piroxicam	Approved Investigational	MINK1	50488	upregulated	Piroxicam results in increased expression of MINK1 mRNA	17p13.2	A23661
Piroxicam	Approved Investigational	MIS18A	54069	downregulated	Piroxicam results in decreased expression of MIS18A mRNA	21q22.11	A23661
Piroxicam	Approved Investigational	MKI67	4288	downregulated	Piroxicam results in decreased expression of MKI67 mRNA	10q26.2	A23661
Piroxicam	Approved Investigational	MLLT11	10962	downregulated	Piroxicam results in decreased expression of MLLT11 mRNA	1q21.3	A23661
Piroxicam	Approved Investigational	MMP10	4319	downregulated	Piroxicam results in decreased expression of MMP10 mRNA	11q22.2	A21015
Piroxicam	Approved Investigational	MOB1A	55233	downregulated	Piroxicam results in decreased expression of MOB1A mRNA	2p13.1	A23661
Piroxicam	Approved Investigational	MRPL13	28998	downregulated	Piroxicam results in decreased expression of MRPL13 mRNA	8q24.12	A23661
Piroxicam	Approved Investigational	MRPL16	54948	downregulated	Piroxicam results in decreased expression of MRPL16 mRNA	11q12.1	A23661

Displaying entries 59326 - 59350 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability